Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-15-040051
Filing Date
2015-05-21
Accepted
2015-05-21 17:25:44
Documents
5
Period of Report
2015-05-21

Document Format Files

Seq Description Document Type Size
1 6-K a15-12546_16k.htm 6-K 20459
2 EX-99.1 a15-12546_1ex99d1.htm EX-99.1 13683
3 EX-99.2 a15-12546_1ex99d2.htm EX-99.2 11562
4 GRAPHIC g125461moi001.jpg GRAPHIC 5176
5 GRAPHIC g125461mmi001.jpg GRAPHIC 5124
  Complete submission text file 0001104659-15-040051.txt   61352
Mailing Address 91 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 91 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37368 | Film No.: 15883738
SIC: 2836 Biological Products, (No Diagnostic Substances)